Latest Views & News

Take a Look at the Bug-Beating Treatment That Could Win a US Licence in the Next Few Weeks

By Malcolm Stacey | Tuesday 15 January 2019

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.

Hello Share Crashers. Everyone knows that unless we find new antibiotics, the world will be in an awful mess. The bugs that kill us are becoming immune to antibiotics because we have over-used them. What we need are different antibiotics which germs have not had the chance to get used to...

You must be a registered member to read this story
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £5.99 per month for all articles, the Bearcast, and our seven year archive.

Filed under:

Subscribe to our newsletter

Daily digest of our latest stories.

Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was